GSK3B and early-onset autosomal dominant Alzheimer disease: Notably, overexpression of Gsk3b in the murine hippocampus causes dramatic alterations in both the dendritic tree morphology and the postsynaptic densities of newborn neurons and has been proposed as a target for the treatment of Alzheimer's disease [23].